{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:41:00Z","timestamp":1791945660585,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd009412","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000}}],"reference-count":176,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009412.pub2","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T15:41:58Z","timestamp":1523374918000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation)"],"prefix":"10.1002","volume":"2018","author":[{"given":"Edoardo G","family":"Ostinelli","sequence":"first","affiliation":[{"name":"Universit\u00e0 degli Studi di Milano; Department of Health Sciences; Via Antonio di Rudin\u00ec 8 Milan Italy 20142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Hussein","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Queens Medical Centre; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzair","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Rathbone Hospital, Mersey Care NHS Foundation Trust; Mental Health; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz-ur","family":"Rehman","sequence":"additional","affiliation":[{"name":"Lytham Hospital, Lancashire Care NHS Foundation Trust; Lytham Lancashire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Miramontes","sequence":"additional","affiliation":[{"name":"Home; 19 Maureen Christian House Desborough Crescent Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive E","family":"Adams","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health Innovation Park, Triumph Road, Nottingham UK NG7 2TU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"10.1002\/14651858.CD009412.pub2-BIB0001|cit1","first-page":"2061","article-title":"The comparative study of quetiapine versus risperidol for agressive behaviour in people with schizophrenia","volume":"17","author":"Dai","year":"2012","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"14","key":"10.1002\/14651858.CD009412.pub2-BIB0002|cit2","first-page":"160","article-title":"Efficacy of magnesium valproate for impulsive aggressive behavior in schizophrenia","volume":"7","author":"Jin","year":"2013","journal-title":"Chinese Journal of Modern Drug Application [\u4e2d\u56fd\u73b0\u4ee3\u836f\u7269\u5e94\u7528]"},{"issue":"01","key":"10.1002\/14651858.CD009412.pub2-BIB0003|cit3","first-page":"69","article-title":"Magnesium valproate sustained-release tablets in combination with risperidone for impulsive aggressive behavior in people with schizophrenia","volume":"20","author":"Li","year":"2013","journal-title":"Journal of Practical Medical Techniques [\u5b9e\u7528\u533b\u6280\u6742\u5fd7]"},{"issue":"1-3","key":"10.1002\/14651858.CD009412.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0920-9964(08)70797-7","article-title":"Comparison of risperidone orodispersible tablet and intramuscular haloperidol in treatment of acute psychotic agitation: a prospective and randomized study","volume":"102","author":"Kim","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S467","DOI":"10.1016\/S0924-977X(07)70712-5","article-title":"Risperidone orodispersible tablet and intramuscular haloperidol in treatment of acute psychotic agitation","volume":"17","author":"Kim","year":"2007","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000315437","article-title":"Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study","volume":"62","author":"Lim","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/JCP.0000000000000050","article-title":"Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine","volume":"34","author":"Walther","year":"2014","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD009412.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"A77","DOI":"10.1055\/s-0033-1353338","article-title":"Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized controlled study with oral haloperidol, risperidone, and olanzapine","volume":"46","author":"Walther","year":"2013","journal-title":"Pharmacopsychiatry"},{"issue":"24","key":"10.1002\/14651858.CD009412.pub2-BIB0009|cit9","first-page":"2956","article-title":"A comparative study of risperidone merger oxcarbazepine in the treatment of schizophrenia agitation","volume":"24","author":"Wang","year":"2012","journal-title":"Medical Journal of Chinese Civil Administration [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"01","key":"10.1002\/14651858.CD009412.pub2-BIB0010|cit10","first-page":"72","article-title":"Clinical observation of treatment with impulsive and aggressive behavior in patients with schizophrenia risperidone combined with valproate","volume":"6","author":"Wang","year":"2013","journal-title":"Chinese Journal of Clinical Rational Drug Use [\u4e34\u5e8a\u5408\u7406\u7528\u836f\u6742\u5fd7]"},{"issue":"22","key":"10.1002\/14651858.CD009412.pub2-BIB0011|cit11","first-page":"2713","article-title":"Short-term efficacy of risperidone combined with magnesium valproate retard tablets on aggressive behavior in patients with schizophrenia","volume":"26","author":"Yao","year":"2010","journal-title":"Occupation and Health"},{"issue":"04","key":"10.1002\/14651858.CD009412.pub2-BIB0012|cit12","first-page":"261","article-title":"Risperidone monotherapy or in combination with valproate for agitation associated with schizophrenia","volume":"23","author":"Zhou","year":"2013","journal-title":"Journal of Clinical Psychological Medicine [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0013|cit13","first-page":"461","article-title":"Risperidone in the management of violent, treatment resistant schizophrenics hospitalized in a maximum security forensic facility","volume":"25","author":"Beck","year":"1997","journal-title":"Journal of the American Academy of Psychiatry and the Law"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009412.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/S0924-977X(05)80278-0","article-title":"Open comparative randomized study efficacy and tolerability of risperidone, olanzapine and quetiapine in acute mania","volume":"15","author":"Belenkaya","year":"2005","journal-title":"European Neuropsychopharmacology"},{"issue":"2-3","key":"10.1002\/14651858.CD009412.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0920-9964(01)00322-X","article-title":"Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients","volume":"57","author":"Briken","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0016|cit16","first-page":"173","article-title":"Aggression and schizophrenia: efficacy of risperidone","volume":"25","author":"Buckley","year":"1997","journal-title":"Journal of the American Academy of Psychiatry and the Law"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4088\/JCP.v62n0405","article-title":"A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities","volume":"62","author":"Buitelaar","year":"2001","journal-title":"Journal of Clinical Psychiatry [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/JCP.0b013e31829e8168","article-title":"An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation","volume":"33","author":"Chan","year":"2013","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD009412.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1176\/appi.ps.52.11.1510","article-title":"Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia","volume":"52","author":"Citrome","year":"2001","journal-title":"Psychiatric Services"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0020|cit20","unstructured":"Citrome LL Volavka J Czobor P Nolan K Lieberman JA Lindenmayer JP Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol 156th Annual Meeting of the American Psychiatric Association; 2003 May 17-22; San Francisco, California, USA 2003"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0021|cit21","unstructured":"Citrome LL Volavka J Czobor P Sheitman BB Lindenmayer JP McEvoy JP Atypical antipsychotics and hostility in schizophrenia: a DOUBLE-BLIND study 154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans, Louisiana, USA Marathon Multimedia 2001"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0022|cit22","unstructured":"Citrome LL Volavka J Czobor P Sheitman BB Lindenmayer JP McEvoy JP Atypical antipsychotics and hostility in schizophrenia: a DOUBLE-BLIND study 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, Pennsylvania, USA 2002"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/jnp.2006.18.4.509","article-title":"Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder","volume":"18","author":"Hoptman","year":"2006","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpsychires.2004.04.010","article-title":"Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder","volume":"39","author":"Nolan","year":"2005","journal-title":"Journal of Psychiatric Research"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.jcp.0000117424.05703.29","article-title":"Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol","volume":"24","author":"Volavka","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009412.pub2-BIB0027|cit26","first-page":"74","article-title":"Schizophrenia and valproate","volume":"37","author":"Citrome","year":"2003","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD009412.pub2-BIB0026|cit27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/appi.ps.55.3.290","article-title":"Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone","volume":"55","author":"Citrome","year":"2004","journal-title":"Psychiatric Services"},{"issue":"6","key":"10.1002\/14651858.CD009412.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/YIC.0b013e3281c61baf","article-title":"Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility","volume":"22","author":"Citrome","year":"2007","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0029|cit29","unstructured":"NCT00308360 Risperidone alone vs risperidone plus valproate in the treatment of patients with schizophrenia and hostility www.clinicaltrials.gov\/ct2\/show\/NCT00308360"},{"issue":"3","key":"10.1002\/14651858.CD009412.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11126-009-9104-8","article-title":"Staff and patient views of the reasons for aggressive incidents: a prospective, incident-based study","volume":"80","author":"Nolan","year":"2009","journal-title":"Psychiatric Quarterly"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0031|cit31","first-page":"29","article-title":"A randomized trial of oral risperidone versus intramuscular haloperidol in the emergency treatment of acute psychotic agitation","volume":"12","author":"Conde","year":"2011","journal-title":"ASEAN Journal of Psychiatry"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD009412.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1016\/S0924-977X(00)80324-7","article-title":"Risperidone oral solution versus intramuscular haloperidol for control of psychotic agitation","volume":"10","author":"Currier","year":"2000","journal-title":"European Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD009412.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4088\/JCP.v62n0303","article-title":"Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation","volume":"62","author":"Currier","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD009412.pub2-BIB0034|cit34","first-page":"191","article-title":"A pragmatic and convenient approach for the management of acute agitation: results from a series of clinical studies","volume":"53","author":"Gharabawi","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0035|cit35","unstructured":"Simpson GM Morein JD Reyes-Harde M Gharabawi G A pragmatic and convenient approach for the management of acute agitation: results from a series of clinical studies 16th European College of Neuropsychopharmacology Congress; 2003 Sep 20-24; Prague, Czech Republic 2003"},{"issue":"3","key":"10.1002\/14651858.CD009412.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4088\/JCP.v65n0315","article-title":"Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam","volume":"65","author":"Currier","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0037|cit37","unstructured":"Gharabawi G Turkoz I Pandina G Emergency treatment of acute agitation in patients with schizophrenia and schizoaffective disorder: oral risperidone + lorazepam versus IM haloperidol + lorazepam International Congress on Schizophrenia Research Biennial Meeting; March 29-April 2, 2003; Colorado Springs, Colorado, USA 2003"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0920-9964(03)80463-2","article-title":"Oral risperidone + lorazepam versus IM haloperidol + lorazepam in the emergency treatment of acute psychosis in schizophrenia and schizoaffective disorder","volume":"60","author":"Gharabawi","year":"2003","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004714-199508000-00002","article-title":"Effect of risperidone on hostility in schizophrenia","volume":"15","author":"Czobor","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/YIC.0b013e32834fc431","article-title":"Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia","volume":"27","author":"Fang","year":"2012","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0041|cit41","unstructured":"ACTRN12607000608460 A randomised placebo controlled trial of intensive psychosocial treatment plus or minus anti-psychotic medication for first episode psychosis with low-risk of self-harm or aggression. The STAGES Study: Staged Treatment and Acceptability Guidelines in Early Psychosis https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=82439 2007"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD009412.pub2-BIB0042|cit42","first-page":"S503","article-title":"Risperidone vs quetiapine in inpatients with schizophrenia: a double-blind placebo-controlled study","volume":"15","author":"Greenspan","year":"2005","journal-title":"European Neuropsychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD009412.pub2-BIB0043|cit43","first-page":"631","article-title":"Efficacy of risperidone, clonazepam in the treatment of schizophrenia","volume":"27","author":"Han","year":"2005","journal-title":"Ningxia Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.genhosppsych.2008.03.004","article-title":"Olanzapine orally disintegrating tablet vs risperidone oral solution in the treatment of acutely agitated psychotic patients","volume":"30","author":"Hatta","year":"2008","journal-title":"General Hospital Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0045|cit45","first-page":"118","article-title":"A controlled study on hostility and side effects in clozapine and risperidone for treatment of patients with schizophrenia","volume":"22","author":"He","year":"2005","journal-title":"Journal of Xinxiang Medical College"},{"issue":"6","key":"10.1002\/14651858.CD009412.pub2-BIB0046|cit46","first-page":"480","article-title":"Clinical analysis of modern electro - convulsive treatment of schizophrenia","volume":"8","author":"Hong","year":"2014","journal-title":"For All Health [\u5927\u5bb6\u5065\u5eb7]"},{"issue":"7","key":"10.1002\/14651858.CD009412.pub2-BIB0047|cit47","first-page":"787","article-title":"Risperidone oral solution with lorazepam treatment of schizophrenia excited state","volume":"19","author":"Hou","year":"2011","journal-title":"Chinese Journal of Health Psychology"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0048|cit48","first-page":"S293","article-title":"Risperidone versus zuclopentixol in acute psychosis in emergency psychiatry: a prospective naturalistic study","volume":"13","author":"Hovens","year":"2003","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0269881105048897","article-title":"Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study","volume":"19","author":"Hovens","year":"2005","journal-title":"Journal of Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD009412.pub2-BIB0050|cit50","first-page":"282","article-title":"Efficacy and safety of oxcarbazepine as adjuvant therapy in excited patients with schizophrenia and schizophreniform psychosis","volume":"21","author":"Huaqiang","year":"2009","journal-title":"Shanghai Archives of Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0051|cit51","unstructured":"ISRCTN11736448 Neuroleptics in adults with aggressive challenging behaviour and intellectual disability www.isrctn.com\/ISRCTN11736448"},{"issue":"11","key":"10.1002\/14651858.CD009412.pub2-BIB0052|cit52","first-page":"1604","article-title":"The controlled clinical study of combined oral risperidone and clonazepam with intramuscular haloperidol replaced by oral risperidone","volume":"20","author":"Jiang","year":"2012","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"6","key":"10.1002\/14651858.CD009412.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.160.6.1125","article-title":"Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic","volume":"160","author":"Kane","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0054|cit54","unstructured":"Kirwan J Brodaty H Ames D Snowdon J Woodward M Clarnette R Risperidone in the treatment of agitation and psychosis of dementia 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, Pennsylvania, USA 2002"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0055|cit55","unstructured":"Kolivakis TT Margolese HC Beauclair L Chouinard G Adjunctive anticonvulsant use in first-episode schizophrenia 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, Pennsylvania, USA 2002"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0056|cit56","unstructured":"Lewis CF Haloperidol versus risperidone in the treatment of aggressive psychotic male inmates 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25; Toronto, Canada 2006"},{"issue":"11","key":"10.1002\/14651858.CD009412.pub2-BIB0057|cit57","first-page":"53","article-title":"A comparative study of antipsychotic drugs combined with small doses of magnesium valproate in the treatment of schizophrenia","volume":"3","author":"Li","year":"2014","journal-title":"World Health Digest [\u4e2d\u5916\u5065\u5eb7\u6587\u6458]"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0058|cit58","unstructured":"Lieberman JA Risperidone and clozapine in chronic schizophrenia CRISP database (https:\/\/www-commons.cit.nih.gov\/crisp\/index.html accessed 19th February 2001) 2001"},{"issue":"17","key":"10.1002\/14651858.CD009412.pub2-BIB0059|cit59","first-page":"2245","article-title":"Clinical study of olanzapine and risperidone in the treatment of Schizophrenia","volume":"22","author":"Liu","year":"2010","journal-title":"Chinese Journal of Mental Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"35","key":"10.1002\/14651858.CD009412.pub2-BIB0060|cit60","first-page":"104","article-title":"Randomized controlled study of the efficacy of short-term risperidone combined with intramuscular haloperidol in the treatment of acute agitation in schizophrenia behavior","volume":"12","author":"Liu","year":"2012","journal-title":"China Medical Herald [\u4e2d\u56fd\u533b\u836f\u5bfc\u62a5]"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0061|cit61","unstructured":"NCT00174200 A randomized, double-blind, crossover add-on study to assess the differential sensitivity of 2 spatial working memory tests (the Groton Maze Learning Test [GMLT] and the Motor Delayed Response Test [MDR]) in non-agitated, antipsychotic drug-naive first-episode schizophrenic or schizophreniform patients treated with risperidone 2 mg daily or placebo www.clinicaltrials.gov\/ct2\/show\/NCT00174200"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0062|cit62","unstructured":"NCT00203775 Efficacy of risperidone versus haloperidol in the treatment of aggression and hostility in psychotic inmates www.clinicaltrials.gov\/ct2\/show\/NCT00203775"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0063|cit63","unstructured":"NCT00205699 Metabolic effects of antipsychotics in children www.clinicaltrials.gov\/ct2\/show\/NCT00205699"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0064|cit64","unstructured":"NCT00418873 A multi-centre comparative study to evaluate the anti-aggression effect and safety of zotepine versus risperidone in aggressive schizophrenic patients in an acute ward www.clinicaltrials.gov\/ct2\/show\/NCT00418873"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0065|cit65","unstructured":"Eli Lilly Managing acute schizophrenia, a comparison between two atypical antipsychotics Eli Lilly and Company Clinical Trial Registry 2003"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0066|cit66","unstructured":"NCT00485498 Managing acute schizophrenia, a double blind comparison between two atypical antipsychotics - olanzapine and risperidone www.clinicaltrials.gov\/ct2\/show\/NCT00485498"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0067|cit67","first-page":"117","article-title":"A control study on risperidone combined with clozapine in the treatment of schizophrenia with aggressive behavior","volume":"13","author":"Ou","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD009412.pub2-BIB0068|cit68","first-page":"405","article-title":"Oral risperidone treatment of schizophrenia clinical observation of excited agitation","volume":"19","author":"Pei","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD009412.pub2-BIB0069|cit69","first-page":"168","article-title":"Comparative study of ziprasidone and risperidone in the treatment of female patients with schizophrenia","volume":"22","author":"Peng","year":"2009","journal-title":"Sichuan Mental Health"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0070|cit70","first-page":"501","article-title":"A placebo - controlled study of risperidone vs quetiapine for symptom response and readiness for discharge among agitated inpatients with schizophrenia","volume":"31","author":"Potkin","year":"2005","journal-title":"Schizophrenia Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/S0924-977X(03)92085-2","article-title":"Reduced relapse rates in recent onset schizophrenia patients treated with risperidone vs. haloperidol","volume":"13","author":"Schooler","year":"2003","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ebmh.12.1.13","article-title":"Antipsychotic medications do not differ substantially in ability to reduce violent behaviour in people with schizophrenia","volume":"12","author":"Covell","year":"2009","journal-title":"Evidence-Based Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1192\/bjp.bp.107.042630","article-title":"Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia","volume":"193","author":"Swanson","year":"2008","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD009412.pub2-BIB0074|cit74","first-page":"153","article-title":"A clinical study of risperidone oral solution combined with clonazepam injection in the treatment of acute excitement phase schizophrenia patient","volume":"19","author":"Tang","year":"2007","journal-title":"Shanghai Archives of Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0075|cit75","unstructured":"NCT01193153 A study to evaluate the efficacy of paliperidone palmitate in the prevention of relapse of the symptoms of schizoaffective disorder https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01193153 2007"},{"issue":"Sppl 3","key":"10.1002\/14651858.CD009412.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"S532","DOI":"10.1016\/S0924-977X(09)70845-4","article-title":"Adjunctive mood stabilising treatment: the effects on hostility and impulsivity among patients with schizophrenia","volume":"19","author":"Tosic Golubovic Suzana","year":"2009","journal-title":"European Neuropsychopharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD009412.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1016\/S0924-977X(02)80465-5","article-title":"Oral risperidone in the management of agitated behavior in emergency settings","volume":"12","author":"Veser","year":"2002","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00131746-200603000-00005","article-title":"Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double blind, placebo-controlled trial","volume":"12","author":"Veser","year":"2006","journal-title":"Journal of Psychiatric Practice"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pnpbp.2007.09.007","article-title":"Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation","volume":"32","author":"Villari","year":"2008","journal-title":"Progress in Neuro-psychopharmacology and Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0080|cit80","first-page":"23","article-title":"Curative effect of risperidone with BDZs in the treatment of excitement and agitate with schizophrenia in acute phase","volume":"13","author":"Wan","year":"2005","journal-title":"Health Psychology Journal"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0081|cit81","first-page":"88","article-title":"A multicenter study of risperidone treatment for acute agitation in patients with schizophrenia","volume":"37","author":"Wang","year":"2004","journal-title":"Chinese Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0082|cit82","first-page":"441","article-title":"Therapeutic effect of risperidone combined with magnesium valproate in aggressive behaviors of schizophrenics","volume":"14","author":"Wang","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"6","key":"10.1002\/14651858.CD009412.pub2-BIB0083|cit83","first-page":"117","article-title":"Observation of curative effect of electroconvulsive therapy in treatment of aggressive behaviour in Schizophrenia","volume":"21","author":"Wang","year":"2015","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"issue":"11","key":"10.1002\/14651858.CD009412.pub2-BIB0084|cit84","first-page":"1414","article-title":"Olanzapine and risperidone in adolescent schizophrenia starting control study of 60 cases","volume":"22","author":"Wei","year":"2010","journal-title":"Medical Journal of Chinese Peoples Health"},{"issue":"12","key":"10.1002\/14651858.CD009412.pub2-BIB0085|cit85","first-page":"43","article-title":"A study of additive effect of magnesium valproate in the treatment of schizophrenia","volume":"5","author":"Xi","year":"2010","journal-title":"Chinese Journal of Practical Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0086|cit86","first-page":"244","article-title":"Clinical observation on the effect of risperidone combined with BZD on schizophrenia","volume":"7","author":"Xuan","year":"2007","journal-title":"China Tropical Medicine"},{"issue":"02","key":"10.1002\/14651858.CD009412.pub2-BIB0087|cit87","first-page":"89","article-title":"Controlled study of risperidone oral solution in combination with clonazepam tablets for acute agitation in schizophrenia","volume":"22","author":"Zhang","year":"2012","journal-title":"The 10th National Conference of Psychiatry [\u4e2d\u534e\u533b\u5b66\u4f1a\u7b2c\u5341\u6b21\u5168\u56fd\u7cbe\u795e\u533b\u5b66\u5b66\u672f\u4f1a\u8bae]"},{"issue":"6","key":"10.1002\/14651858.CD009412.pub2-BIB0088|cit88","first-page":"354","article-title":"Randomized controlled study of psychotic agitation in schizophrenic patients comparing combination treatment with oral risperidone and clonazepam versus initial treatment with intramuscular haloperidol followed by oral risperidone","volume":"22","author":"Zheng","year":"2010","journal-title":"Shandong Archives of Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0089|cit89","first-page":"1123","article-title":"A randomized controlled study of risperidone oral solution combined with clonazepam in the treatment of schizophrenic symptoms","volume":"8","author":"Zhou","year":"2012","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0090|cit90","unstructured":"Herrera M Double blind study with risperidone vs haloperidol in schizophrenic patients with agitation and\/or aggression 8th World Congress of Psychiatry; 2005 Sep 10-15; Cairo, Egypt 2005"},{"issue":"3","key":"10.1002\/14651858.CD009412.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/JCP.0b013e3181db8715","article-title":"Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan","volume":"30","author":"Hsu","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD009412.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1016\/S0924-977X(06)70577-6","article-title":"Risperidone oral solution, therapeutic possibility in treatment of acute and agitated psychotic patients","volume":"16","author":"Lasic","year":"2006","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0093|cit93","unstructured":"NCT00859872 Efficacy and safety of risperidone oral solution combination clonazepam versus haloperidol IM injection for treatment of acute psychotic agitation in schizophrenia www.clinicaltrials.gov\/ct2\/show\/NCT00859872?term=NCT00859872&rank=1"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0094|cit94","first-page":"1","article-title":"Clinical practice guidelines: treatment of schizophrenia","volume":"50","author":"Addington","year":"2005","journal-title":"Canadian Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007445.pub2","article-title":"Chlorpromazine for psychosis-induced aggression or agitation","author":"Ahmed","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0924-977X(01)00097-9","article-title":"Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials","volume":"11","author":"Aleman","year":"2001","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0098|cit98","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia","volume":"161","author":"Lehman","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0149-2918(97)80081-1","article-title":"Cost-effectiveness and quality of live in psychosis: the pharmacoeconomics of risperidone","volume":"19","author":"Aronson","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archpsyc.57.10.979","article-title":"Mental disorders and violence in a total birth cohort. Results from the Dunedin study","volume":"57","author":"Arseneault","year":"2000","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003476.pub2","article-title":"Atypical antipsychotics for aggression and psychosis in Alzheimer's disease","author":"Ballard","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0103|cit103","volume-title":"Psychotropic Drug Directory","author":"Bazire","year":"2009"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003729.pub2","article-title":"Olanzapine IM or velotab for acutely disturbed\/agitated people with suspected serious mental illnesses","author":"Belgamwar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0106|cit106","volume-title":"British National Formulary","volume":"73","author":"Joint Formulary Committee","year":"2017"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0107|cit107","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"issue":"5","key":"10.1002\/14651858.CD009412.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/archpsyc.57.5.494","article-title":"Major mental disorders and criminal violence in a Danish birth cohort","volume":"57","author":"Brennan","year":"2000","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD009412.pub2-BIB0109|cit109","first-page":"52","article-title":"The role of the typical and atypical antipsychotic medications in the management of agitation and aggression","volume":"60","author":"Buckley","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0110|cit110","unstructured":"Central Intelligence Agency The World Factbook www.cia.gov\/library\/publications\/resources\/the-world-factbook\/index.html"},{"issue":"5","key":"10.1002\/14651858.CD009412.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/appi.ajp.158.5.765","article-title":"A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder","volume":"158","author":"Conley","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4088\/JCP.v62n0303","article-title":"Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation","volume":"62","author":"Currier","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0113|cit113","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town The Cochrane Collaboration 2000"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0114|cit114","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD009412.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009922.pub2","article-title":"De-escalation techniques for psychosis-induced aggression or agitation","author":"Du","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD009412.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1176\/ajp.2006.163.8.1397","article-title":"The population impact of severe mental illness on violent crime","volume":"163","author":"Fazel","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00702-006-0602-7","article-title":"Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents","volume":"114","author":"Fleischhaker","year":"2007","journal-title":"Journal of Neural Transmission"},{"issue":"7","key":"10.1002\/14651858.CD009412.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0124|cit124","first-page":"217","article-title":"Clinical Global Impression","volume-title":"ECDEU Assessment Manual for Psychopharmacology (revised)","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2003","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0126|cit126","unstructured":"Higgins JPT Green S (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0127|cit127","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0128|cit128","volume-title":"Methodological Expectations of Cochrane Intervention Reviews","author":"Higgins","year":"2016"},{"issue":"11","key":"10.1002\/14651858.CD009412.pub2-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005146.pub3","article-title":"Haloperidol plus promethazine for psychosis-induced aggression","author":"Huf","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000440","article-title":"Risperidone versus typical antipsychotic medication for schizophrenia","author":"Hunter","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2141.2009.07707.x","article-title":"Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials","volume":"146","author":"Hutton","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3565(25)24408-1","article-title":"Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties","volume":"244","author":"Janssen","year":"1988","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0133|cit133","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub3","article-title":"Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses","author":"Jayakody","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jclinepi.2016.01.002","article-title":"Extracting data from figures with software was faster, with higher interrater reliability than manual extraction","volume":"74","author":"Kadic","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone study group","volume":"60","author":"Katz","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0136|cit136","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"12","key":"10.1002\/14651858.CD009412.pub2-BIB0137|cit137","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002830.pub3","article-title":"Droperidol for psychosis-induced aggression or agitation","author":"Khokhar","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"c365","key":"10.1002\/14651858.CD009412.pub2-BIB0138|cit138","first-page":"1","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD009412.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2005.10.020","article-title":"Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology","volume":"59","author":"Leon","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD009412.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0143|cit143","unstructured":"Mathis MV Atypical Antipsychotics and Pediatrics: Background and Update Psychopharmacological Drugs Advisory Committee Meeting 2009"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02245439","article-title":"Survey on the pharmacodynamics of the new antipsychotic risperidone","volume":"114","author":"Megens","year":"1994","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD009412.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7525-9-18","article-title":"Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room","volume":"9","author":"Montoya","year":"2011","journal-title":"Health Quality Life Outcomes"},{"issue":"3","key":"10.1002\/14651858.CD009412.pub2-BIB0147|cit147","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002084.pub2","article-title":"Containment strategies for people with serious mental illness","author":"Muralidharan","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0148|cit148","unstructured":"National Collaborating Centre for Nursing and Supportive Care The short-term management of disturbed\/violent behaviour in in-patient psychiatric settings and emergency departments www.ncbi.nlm.nih.gov\/books\/NBK55521\/"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0149|cit149","unstructured":"National Institute for Health and Care Excellence Violence and aggression: short-term management in mental health, health and community settings www.nice.org.uk\/guidance\/ng10"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2006-950498","article-title":"Initial treatment of severe acute psychosis with risperidone fast orally disintegrating tablets","volume":"39","author":"Normann","year":"2006","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"10.1002\/14651858.CD009412.pub2-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009377.pub3","article-title":"Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)","author":"Ostinelli","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008074","article-title":"Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation)","author":"Ostinelli","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0154|cit154","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004161.pub2","article-title":"Risperidone (depot) for schizophrenia","author":"Sampson","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1017\/S0033291700045244","article-title":"WHO international pilot study of schizophrenia","volume":"2","author":"Sartorius","year":"1972","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0156|cit156","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In Higgins JPT, Green S editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD009412.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0447.2000.9r004.x","article-title":"Mental health economic studies from developing countries reviewed in the context of those from developed countries","volume":"101","author":"Shah","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0158|cit158","first-page":"11-9","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0159|cit159","volume-title":"Stahl's Essential Psychopharmacology, Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2008"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0160|cit160","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0161|cit161","first-page":"761","article-title":"Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys","volume":"41","author":"Swanson","year":"1990","journal-title":"Hospital and Community Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1176\/ajp.139.2.212","article-title":"Assaultive behavior among chronic inpatients","volume":"139","author":"Tardiff","year":"1982","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD009412.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jclinepi.2008.12.011","article-title":"A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers","volume":"62","author":"Thorpe","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD009412.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-199710000-00010","article-title":"Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders","volume":"17","author":"Tran","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD009412.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"11","key":"10.1002\/14651858.CD009412.pub2-BIB0166|cit166","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010190","article-title":"Loxapine inhaler for psychosis-induced aggression or agitation","author":"Vangala","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD009412.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1176\/ps.48.9.1153","article-title":"Impact of risperidone on the use of mental health care resources","volume":"48","author":"Viale","year":"1997","journal-title":"Psychiatric Services"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0168|cit168","volume-title":"World Report on Violence and Health","author":"World Health Organization","year":"2002"},{"issue":"4","key":"10.1002\/14651858.CD009412.pub2-BIB0169|cit169","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009801","article-title":"Quetiapine for psychosis-induced aggression or agitation","author":"Wilkie","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009412.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v60n0602","article-title":"Novel antipsychotics: comparison of weight gain liabilities","volume":"60","author":"Wirshing","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0171|cit171","unstructured":"World Psychiatric Association The usefulness and use of second-generation antipsychotic medications\u00a0(An update of the review of evidence and recommendations by a task force of the World Psychiatric Association) www.peoplewho.org\/documents\/WPA2ndgenanti-pDOC.doc"},{"key":"10.1002\/14651858.CD009412.pub2-BIB0172|cit172","volume-title":"The Recognition, Prevention and Therapeutic Management of Violence in Acute In-patient Psychiatry: a Literature Review and Evidence-based Recommendations for Good Practice","author":"Wright","year":"2002"},{"issue":"7","key":"10.1002\/14651858.CD009412.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD009412.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1176\/ajp.143.1.35","article-title":"The Overt Aggression Scale for the for the objective rating of verbal and physical aggression","volume":"143","author":"Yudofsky","year":"1986","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD009412.pub2-BIB0175|cit175","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003079.pub4","article-title":"Benzodiazepines for psychosis-induced aggression or agitation","author":"Zaman","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD009412.pub2-BIB0176|cit176","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009412","article-title":"Risperidone for psychosis induced aggression or agitation","author":"Ahmed","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009412.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T15:21:17Z","timestamp":1751556077000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009412.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":176,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009412.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]}}}